The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Paliperidone Market Research Report 2025
Synopsis
Paliperidone, sold under the trade name Invega among others, is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications. It is marketed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing. Paliperidone is mainly used to treat schizophrenia and schizoaffective disorder. It is also used to treat mania and at lower doses as maintenance for bipolar disorder.
The global Paliperidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Paliperidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Paliperidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Paliperidone in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Paliperidone include Janssen Pharmaceutica, Mylan, Teva and Sun Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Paliperidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paliperidone.
Report Scope
The Paliperidone market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paliperidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paliperidone companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen Pharmaceutica
Mylan
Teva
Sun Pharmaceutical
Segment by Type
1.5 mg Tablet
3 mg Tablet
6 mg Tablet
9 mg Tablet
Segment by Application
Adults
Adolescents
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Paliperidone companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Paliperidone, sold under the trade name Invega among others, is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications. It is marketed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing. Paliperidone is mainly used to treat schizophrenia and schizoaffective disorder. It is also used to treat mania and at lower doses as maintenance for bipolar disorder.
The global Paliperidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Paliperidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Paliperidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Paliperidone in Adults is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Paliperidone include Janssen Pharmaceutica, Mylan, Teva and Sun Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Paliperidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paliperidone.
Report Scope
The Paliperidone market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Paliperidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Paliperidone companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen Pharmaceutica
Mylan
Teva
Sun Pharmaceutical
Segment by Type
1.5 mg Tablet
3 mg Tablet
6 mg Tablet
9 mg Tablet
Segment by Application
Adults
Adolescents
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Paliperidone companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paliperidone Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 1.5 mg Tablet
1.2.3 3 mg Tablet
1.2.4 6 mg Tablet
1.2.5 9 mg Tablet
1.3 Market by Application
1.3.1 Global Paliperidone Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adults
1.3.3 Adolescents
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Paliperidone Market Perspective (2019-2030)
2.2 Paliperidone Growth Trends by Region
2.2.1 Global Paliperidone Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Paliperidone Historic Market Size by Region (2019-2024)
2.2.3 Paliperidone Forecasted Market Size by Region (2025-2030)
2.3 Paliperidone Market Dynamics
2.3.1 Paliperidone Industry Trends
2.3.2 Paliperidone Market Drivers
2.3.3 Paliperidone Market Challenges
2.3.4 Paliperidone Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paliperidone Players by Revenue
3.1.1 Global Top Paliperidone Players by Revenue (2019-2024)
3.1.2 Global Paliperidone Revenue Market Share by Players (2019-2024)
3.2 Global Paliperidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Paliperidone Revenue
3.4 Global Paliperidone Market Concentration Ratio
3.4.1 Global Paliperidone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paliperidone Revenue in 2023
3.5 Paliperidone Key Players Head office and Area Served
3.6 Key Players Paliperidone Product Solution and Service
3.7 Date of Enter into Paliperidone Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paliperidone Breakdown Data by Type
4.1 Global Paliperidone Historic Market Size by Type (2019-2024)
4.2 Global Paliperidone Forecasted Market Size by Type (2025-2030)
5 Paliperidone Breakdown Data by Application
5.1 Global Paliperidone Historic Market Size by Application (2019-2024)
5.2 Global Paliperidone Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Paliperidone Market Size (2019-2030)
6.2 North America Paliperidone Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Paliperidone Market Size by Country (2019-2024)
6.4 North America Paliperidone Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Paliperidone Market Size (2019-2030)
7.2 Europe Paliperidone Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Paliperidone Market Size by Country (2019-2024)
7.4 Europe Paliperidone Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Paliperidone Market Size (2019-2030)
8.2 Asia-Pacific Paliperidone Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Paliperidone Market Size by Region (2019-2024)
8.4 Asia-Pacific Paliperidone Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Paliperidone Market Size (2019-2030)
9.2 Latin America Paliperidone Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Paliperidone Market Size by Country (2019-2024)
9.4 Latin America Paliperidone Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paliperidone Market Size (2019-2030)
10.2 Middle East & Africa Paliperidone Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Paliperidone Market Size by Country (2019-2024)
10.4 Middle East & Africa Paliperidone Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Janssen Pharmaceutica
11.1.1 Janssen Pharmaceutica Company Detail
11.1.2 Janssen Pharmaceutica Business Overview
11.1.3 Janssen Pharmaceutica Paliperidone Introduction
11.1.4 Janssen Pharmaceutica Revenue in Paliperidone Business (2019-2024)
11.1.5 Janssen Pharmaceutica Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Paliperidone Introduction
11.2.4 Mylan Revenue in Paliperidone Business (2019-2024)
11.2.5 Mylan Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Paliperidone Introduction
11.3.4 Teva Revenue in Paliperidone Business (2019-2024)
11.3.5 Teva Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Detail
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Paliperidone Introduction
11.4.4 Sun Pharmaceutical Revenue in Paliperidone Business (2019-2024)
11.4.5 Sun Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Paliperidone Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 1.5 mg Tablet
Table 3. Key Players of 3 mg Tablet
Table 4. Key Players of 6 mg Tablet
Table 5. Key Players of 9 mg Tablet
Table 6. Global Paliperidone Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Paliperidone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Paliperidone Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Paliperidone Market Share by Region (2019-2024)
Table 10. Global Paliperidone Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Paliperidone Market Share by Region (2025-2030)
Table 12. Paliperidone Market Trends
Table 13. Paliperidone Market Drivers
Table 14. Paliperidone Market Challenges
Table 15. Paliperidone Market Restraints
Table 16. Global Paliperidone Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Paliperidone Market Share by Players (2019-2024)
Table 18. Global Top Paliperidone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paliperidone as of 2023)
Table 19. Ranking of Global Top Paliperidone Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Paliperidone Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Paliperidone Product Solution and Service
Table 23. Date of Enter into Paliperidone Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Paliperidone Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Paliperidone Revenue Market Share by Type (2019-2024)
Table 27. Global Paliperidone Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Paliperidone Revenue Market Share by Type (2025-2030)
Table 29. Global Paliperidone Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Paliperidone Revenue Market Share by Application (2019-2024)
Table 31. Global Paliperidone Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Paliperidone Revenue Market Share by Application (2025-2030)
Table 33. North America Paliperidone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Paliperidone Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Paliperidone Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Paliperidone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Paliperidone Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Paliperidone Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Paliperidone Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Paliperidone Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Paliperidone Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Paliperidone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Paliperidone Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Paliperidone Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Paliperidone Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Paliperidone Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Paliperidone Market Size by Country (2025-2030) & (US$ Million)
Table 48. Janssen Pharmaceutica Company Detail
Table 49. Janssen Pharmaceutica Business Overview
Table 50. Janssen Pharmaceutica Paliperidone Product
Table 51. Janssen Pharmaceutica Revenue in Paliperidone Business (2019-2024) & (US$ Million)
Table 52. Janssen Pharmaceutica Recent Development
Table 53. Mylan Company Detail
Table 54. Mylan Business Overview
Table 55. Mylan Paliperidone Product
Table 56. Mylan Revenue in Paliperidone Business (2019-2024) & (US$ Million)
Table 57. Mylan Recent Development
Table 58. Teva Company Detail
Table 59. Teva Business Overview
Table 60. Teva Paliperidone Product
Table 61. Teva Revenue in Paliperidone Business (2019-2024) & (US$ Million)
Table 62. Teva Recent Development
Table 63. Sun Pharmaceutical Company Detail
Table 64. Sun Pharmaceutical Business Overview
Table 65. Sun Pharmaceutical Paliperidone Product
Table 66. Sun Pharmaceutical Revenue in Paliperidone Business (2019-2024) & (US$ Million)
Table 67. Sun Pharmaceutical Recent Development
Table 68. Research Programs/Design for This Report
Table 69. Key Data Information from Secondary Sources
Table 70. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paliperidone Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Paliperidone Market Share by Type: 2023 VS 2030
Figure 3. 1.5 mg Tablet Features
Figure 4. 3 mg Tablet Features
Figure 5. 6 mg Tablet Features
Figure 6. 9 mg Tablet Features
Figure 7. Global Paliperidone Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Paliperidone Market Share by Application: 2023 VS 2030
Figure 9. Adults Case Studies
Figure 10. Adolescents Case Studies
Figure 11. Paliperidone Report Years Considered
Figure 12. Global Paliperidone Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Paliperidone Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Paliperidone Market Share by Region: 2023 VS 2030
Figure 15. Global Paliperidone Market Share by Players in 2023
Figure 16. Global Top Paliperidone Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paliperidone as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Paliperidone Revenue in 2023
Figure 18. North America Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Paliperidone Market Share by Country (2019-2030)
Figure 20. United States Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Paliperidone Market Share by Country (2019-2030)
Figure 24. Germany Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Paliperidone Market Share by Region (2019-2030)
Figure 32. China Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Paliperidone Market Share by Country (2019-2030)
Figure 40. Mexico Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Paliperidone Market Share by Country (2019-2030)
Figure 44. Turkey Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Paliperidone Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Janssen Pharmaceutica Revenue Growth Rate in Paliperidone Business (2019-2024)
Figure 47. Mylan Revenue Growth Rate in Paliperidone Business (2019-2024)
Figure 48. Teva Revenue Growth Rate in Paliperidone Business (2019-2024)
Figure 49. Sun Pharmaceutical Revenue Growth Rate in Paliperidone Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
